Wellgistics Health Inc is a healthcare technology and pharmaceutical logistics company. It simplifies the logistics of prescription fulfillment from the manufacturer and provider to the patient. It is focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors.
2022
13
LTM Revenue n/a
LTM EBITDA n/a
$223M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Wellgistics Health has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.
In the most recent fiscal year, Wellgistics Health achieved revenue of $18.1M and an EBITDA of -$4.9M.
Wellgistics Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Wellgistics Health valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $34.4M | $18.1M | XXX | XXX | XXX |
Gross Profit | $5.7M | $2.8M | XXX | XXX | XXX |
Gross Margin | 17% | 15% | XXX | XXX | XXX |
EBITDA | -$7.2M | -$4.9M | XXX | XXX | XXX |
EBITDA Margin | -21% | -27% | XXX | XXX | XXX |
Net Profit | -$2.7M | -$13.6M | XXX | XXX | XXX |
Net Margin | -8% | -75% | XXX | XXX | XXX |
Net Debt | n/a | $0.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Wellgistics Health's stock price is $4.
Wellgistics Health has current market cap of $199M, and EV of $223M.
See Wellgistics Health trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$223M | $199M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Wellgistics Health has market cap of $199M and EV of $223M.
Wellgistics Health's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate Wellgistics Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Wellgistics Health and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $223M | XXX | XXX | XXX |
EV/Revenue | 12.3x | XXX | XXX | XXX |
EV/EBITDA | -45.4x | XXX | XXX | XXX |
P/E | -29.0x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -139.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpWellgistics Health's NTM/LTM revenue growth is n/a
Wellgistics Health's revenue per employee for the last fiscal year averaged $1.4M, while opex per employee averaged $0.6M for the same period.
Over next 12 months, Wellgistics Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Wellgistics Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Wellgistics Health and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -47% | XXX | XXX | XXX | XXX |
EBITDA Margin | -27% | XXX | XXX | XXX | XXX |
EBITDA Growth | -32% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
Revenue per Employee | $1.4M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.6M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 44% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Philips | XXX | XXX | XXX | XXX | XXX | XXX |
Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Wellgistics Health acquired XXX companies to date.
Last acquisition by Wellgistics Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Wellgistics Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Wellgistics Health founded? | Wellgistics Health was founded in 2022. |
Where is Wellgistics Health headquartered? | Wellgistics Health is headquartered in United States of America. |
How many employees does Wellgistics Health have? | As of today, Wellgistics Health has 13 employees. |
Who is the CEO of Wellgistics Health? | Wellgistics Health's CEO is Mr. Brian Norton. |
Is Wellgistics Health publicy listed? | Yes, Wellgistics Health is a public company listed on NAS. |
What is the stock symbol of Wellgistics Health? | Wellgistics Health trades under WGRX ticker. |
When did Wellgistics Health go public? | Wellgistics Health went public in 2025. |
Who are competitors of Wellgistics Health? | Similar companies to Wellgistics Health include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
What is the current market cap of Wellgistics Health? | Wellgistics Health's current market cap is $199M |
What is the current revenue growth of Wellgistics Health? | Wellgistics Health revenue growth between 2023 and 2024 was -47%. |
Is Wellgistics Health profitable? | Yes, Wellgistics Health is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.